Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1949 1
1951 1
1952 3
1953 5
1954 9
1955 14
1956 9
1957 28
1958 28
1959 15
1960 1
1961 1
1962 1
1964 7
1965 29
1966 53
1967 84
1968 92
1969 106
1970 151
1971 143
1972 187
1973 266
1974 252
1975 231
1976 264
1977 280
1978 279
1979 312
1980 359
1981 399
1982 432
1983 481
1984 562
1985 613
1986 612
1987 626
1988 649
1989 711
1990 808
1991 780
1992 828
1993 934
1994 1087
1995 1127
1996 1142
1997 1133
1998 1188
1999 1286
2000 1353
2001 1403
2002 1584
2003 1763
2004 1906
2005 2127
2006 2290
2007 2288
2008 2434
2009 2747
2010 3052
2011 3357
2012 3716
2013 3846
2014 4155
2015 4397
2016 4418
2017 4556
2018 4888
2019 5315
2020 5463
2021 5350
2022 5251
2023 4741
2024 2367

Text availability

Article attribute

Article type

Publication date

Search Results

92,702 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Lung benign neoplasm"
Page 1
Lung cancer staging: a concise update.
Rami-Porta R, Call S, Dooms C, Obiols C, Sánchez M, Travis WD, Vollmer I. Rami-Porta R, et al. Eur Respir J. 2018 May 17;51(5):1800190. doi: 10.1183/13993003.00190-2018. Print 2018 May. Eur Respir J. 2018. PMID: 29700105 Free article. Review.
Diagnosis and clinical staging of lung cancer are fundamental to planning therapy. ...The present review complements the latest guidelines on lung cancer staging by providing an update of all these issues....
Diagnosis and clinical staging of lung cancer are fundamental to planning therapy. ...The present review complements the lates …
Exercise and lung cancer surgery: A systematic review of randomized-controlled trials.
Himbert C, Klossner N, Coletta AM, Barnes CA, Wiskemann J, LaStayo PC, Varghese TK Jr, Ulrich CM. Himbert C, et al. Crit Rev Oncol Hematol. 2020 Dec;156:103086. doi: 10.1016/j.critrevonc.2020.103086. Epub 2020 Sep 13. Crit Rev Oncol Hematol. 2020. PMID: 33038630 Free PMC article.
Lung cancer patients undergoing surgery are often left physically deconditioned and/or with functional deficits. Exercise interventions may improve pulmonary and physical function before and after lung resection. We conducted a systematic review of randomized …
Lung cancer patients undergoing surgery are often left physically deconditioned and/or with functional deficits. Exercise interventio …
Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment.
Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM. Fahrmann JF, et al. J Clin Oncol. 2022 Mar 10;40(8):876-883. doi: 10.1200/JCO.21.01460. Epub 2022 Jan 7. J Clin Oncol. 2022. PMID: 34995129 Free PMC article.
METHODS: A blinded validation study was performed using prostate lung colorectal ovarian (PLCO) Cancer Screening Trial data and biospecimens to evaluate the performance of a four-marker protein panel (4MP) consisting of the precursor form of surfactant protein B, ca …
METHODS: A blinded validation study was performed using prostate lung colorectal ovarian (PLCO) Cancer Screening Trial data an …
AI Improves Nodule Detection on Chest Radiographs in a Health Screening Population: A Randomized Controlled Trial.
Nam JG, Hwang EJ, Kim J, Park N, Lee EH, Kim HJ, Nam M, Lee JH, Park CM, Goo JM. Nam JG, et al. Radiology. 2023 Apr;307(2):e221894. doi: 10.1148/radiol.221894. Epub 2023 Feb 7. Radiology. 2023. PMID: 36749213 Clinical Trial.
Materials and Methods In this single-center, pragmatic, open-label randomized controlled trial, participants who underwent chest radiography between July 2020 and December 2021 in a health screening center were enrolled and randomized into intervention (AI gr …
Materials and Methods In this single-center, pragmatic, open-label randomized controlled trial, participants who underwent che …
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.
Ginsberg RJ, Rubinstein LV. Ginsberg RJ, et al. Ann Thorac Surg. 1995 Sep;60(3):615-22; discussion 622-3. doi: 10.1016/0003-4975(95)00537-u. Ann Thorac Surg. 1995. PMID: 7677489 Clinical Trial.
BACKGROUND: It has been reported that limited resection (segment or wedge) is equivalent to lobectomy in the management of early stage (T1-2 N0) non-small cell lung cancer. METHODS: A prospective, multiinstitutional randomized trial was instituted comparing l …
BACKGROUND: It has been reported that limited resection (segment or wedge) is equivalent to lobectomy in the management of early stage (T1-2 …
Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.
Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, Dodwell D, Ewertz M, Gray R, Jagsi R, Pierce L, Pritchard KI, Swain S, Wang Z, Wang Y, Whelan T, Peto R, McGale P; Early Breast Cancer Trialists’ Collaborative Group. Taylor C, et al. J Clin Oncol. 2017 May 20;35(15):1641-1649. doi: 10.1200/JCO.2016.72.0722. Epub 2017 Mar 20. J Clin Oncol. 2017. PMID: 28319436 Free PMC article.
Second, individual patient data meta-analyses of 40,781 women randomly assigned to breast cancer radiotherapy versus no radiotherapy in 75 trials yielded rate ratios (RRs) for second primary cancers and cause-specific mortality and excess RRs (ERRs) per Gy for incident …
Second, individual patient data meta-analyses of 40,781 women randomly assigned to breast cancer radiotherapy versus no radiotherapy …
Pafolacianine for intraoperative molecular imaging of cancer in the lung: The ELUCIDATE trial.
Sarkaria IS, Martin LW, Rice DC, Blackmon SH, Slade HB, Singhal S; ELUCIDATE Study Group. Sarkaria IS, et al. J Thorac Cardiovasc Surg. 2023 Dec;166(6):e468-e478. doi: 10.1016/j.jtcvs.2023.02.025. Epub 2023 Mar 3. J Thorac Cardiovasc Surg. 2023. PMID: 37019717 Clinical Trial.
OBJECTIVE: The study objective was to determine the clinical utility of pafolacianine, a folate receptor-targeted fluorescent agent, in revealing by intraoperative molecular imaging folate receptor alpha positive cancers in the lung and narrow surgical margins that …
OBJECTIVE: The study objective was to determine the clinical utility of pafolacianine, a folate receptor-targeted fluorescent agent, …
Targeting PP2A for cancer therapeutic modulation.
Ronk H, Rosenblum JS, Kung T, Zhuang Z. Ronk H, et al. Cancer Biol Med. 2022 Nov 1;19(10):1428-39. doi: 10.20892/j.issn.2095-3941.2022.0330. Cancer Biol Med. 2022. PMID: 36342229 Free PMC article. Review.
LB100, a water-soluble, small-molecule competitive inhibitor of PP2A, has shown particular promise as a chemo- and radio-sensitizing agent. Preclinical success has led to a profusion of clinical trials on LB100 adjuvant therapies, including a phase I trial in extens …
LB100, a water-soluble, small-molecule competitive inhibitor of PP2A, has shown particular promise as a chemo- and radio-sensitizing agent. …
Aerosolized chemotherapy.
Gagnadoux F, Hureaux J, Vecellio L, Urban T, Le Pape A, Valo I, Montharu J, Leblond V, Boisdron-Celle M, Lerondel S, Majoral C, Diot P, Racineux JL, Lemarie E. Gagnadoux F, et al. J Aerosol Med Pulm Drug Deliv. 2008 Mar;21(1):61-70. doi: 10.1089/jamp.2007.0656. J Aerosol Med Pulm Drug Deliv. 2008. PMID: 18518832 Free article. Review.
Regional chemotherapy has been proposed as a treatment modality in a number of cancer settings. In primary or metastatic lung cancer, administration of chemotherapy via inhalation could increase exposure of lung tumor to the drug, while minimizing systemic side effe …
Regional chemotherapy has been proposed as a treatment modality in a number of cancer settings. In primary or metastatic lung cancer, …
Radionuclide Therapy for Neuroendocrine Tumors.
Cives M, Strosberg J. Cives M, et al. Curr Oncol Rep. 2017 Feb;19(2):9. doi: 10.1007/s11912-017-0567-8. Curr Oncol Rep. 2017. PMID: 28220446 Review.
The two radiopeptides most commonly used for PRRT, (90)Y-DOTATOC and (177)Lu-DOTATATE, have been successfully employed for more than a decade for the treatment of advanced neuroendocrine tumors (NETs). Recently, the phase III, randomized NETTER-1 trial has compared …
The two radiopeptides most commonly used for PRRT, (90)Y-DOTATOC and (177)Lu-DOTATATE, have been successfully employed for more than a decad …
92,702 results
You have reached the last available page of results. Please see the User Guide for more information.